Cibus Inc. Class A Common Stock (CBUS)
Stock · NASDAQ · Industrials
$1.32as of 10/16/2026
Price chart
Active signals
CBUS Signal Track Record
How signals performed across all stocks →What CBUS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | -0.5% | 48% | September 29, 2026 |
| Bollinger Band Breakdown | 23 | +5.7% | 57% | September 28, 2026 |
| Bollinger Band Breakout | 20 | +2.6% | 55% | October 2, 2026 |
| 200-Day Moving Average TouchActive now | 8 | -4.8% | 50% | July 16, 2026 |
| Any 20-session window (baseline) | -3.9% | 44% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CBUS
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing…
- Sector
- Industrials
- Industry
- Agricultural Chemicals
- Employees
- 118
- Website
- www.cibus.com/
Fundamentals
- 1-day range
- $1.41$1.5
- Market cap
- $142.74M
- P/E (trailing)
- —
- P/E (forward)
- -2.22
- EPS (trailing)
- $-1.65
- Dividend yield
- —
- Beta
- 1.69
- Avg. volume
- 171.2K
How Cibus Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 17, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Cibus Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- CBUSCibus Inc. Class A Common Stock$1.32▲ 2.33%Market cap $142.74MP/E —$1.09$4.19
- AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.06▼ 15.20%Market cap $88.01MP/E —$1.13$5.55
- BIOXBioceres Crop Solutions Corp. Ordinary Shares$0.276▼ 6.12%Market cap $22.76MP/E —$0.28$2.19
- FRTTFort Technology Inc. Common Shares$0.54▼ 10.00%Market cap $14.75MP/E —$0.6003$4.09
- EVGNEvogene Ltd Ordinary Shares$0.39▼ 2.50%Market cap $9.08MP/E —$0.3521$1.49
- SNESSenesTech Inc. Common Stock$0.647▼ 7.44%Market cap $6.74MP/E —$0.6101$4.19
- NXTSNexentis Technologies Inc. Common Stock$0.645▼ 5.43%Market cap $2.80MP/E —$0.6$32.9
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CBUS Cibus Inc. Class A Common Stock | $142.74M | — | $1.32 | ▲ 2.33% | $1.09$4.19 |
| AVD American Vanguard Corporation Common Stock ($0.10 Par Value) | $88.01M | — | $1.06 | ▼ 15.20% | $1.13$5.55 |
| BIOX Bioceres Crop Solutions Corp. Ordinary Shares | $22.76M | — | $0.276 | ▼ 6.12% | $0.28$2.19 |
| FRTT Fort Technology Inc. Common Shares | $14.75M | — | $0.54 | ▼ 10.00% | $0.6003$4.09 |
| EVGN Evogene Ltd Ordinary Shares | $9.08M | — | $0.39 | ▼ 2.50% | $0.3521$1.49 |
| SNES SenesTech Inc. Common Stock | $6.74M | — | $0.647 | ▼ 7.44% | $0.6101$4.19 |
| NXTS Nexentis Technologies Inc. Common Stock | $2.80M | — | $0.645 | ▼ 5.43% | $0.6$32.9 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Craig Wichner · June 8, 2026 · Grant1.05M
- Craig Wichner · June 8, 2026 · Grant894.3K
- Moretti August J · June 2, 2026 · Grant77.6K
- Rory B. Riggs · June 2, 2026 · Grant77.6K
- Finn Mark Terrence · June 2, 2026 · Grant77.6K
- Gerhard Prante · June 2, 2026 · Grant64.7K
- Jean-Pierre Jules Lehmann · June 2, 2026 · Grant64.7K
- Craig Wichner · June 2, 2026 · Grant77.6K
- Thomas Urban · June 2, 2026 · Grant64.7K
- Box Kimberly Ann · June 2, 2026 · Grant77.6K
- Carlo Broos · April 24, 2026 · Grant114.0K
- Carlo Broos · April 24, 2026 · Grant57.0K
- Thomas Urban · April 24, 2026 · Grant9.1K
- Noel Sauer · April 24, 2026 · Grant76.0K
- Noel Sauer · April 24, 2026 · Grant38.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 21.90M
- Total value held
- $43.06M
- Institutional holders
- 65
- Unknown11.43M
- Unknown2.12M
- Unknown1.53M
- Unknown888.1K
- Unknown576.0K
- Unknown482.9K
- Unknown425.0K
- Unknown415.2K
- Unknown328.2K
- Unknown318.2K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Cibus Partners with Crystal Crop Protection for Mustard Traits
Cibus has agreed to collaborate with Crystal Crop Protection to develop gene-edited traits for mustard crops in India. This partnership aims to improve Brassica Juncea varieties, marking a strategic step in the company's agricultural technology efforts. The stock is currently trading near its 52-week low, with recent technical signals indicating high volatility.
Cibus Partners with Crystal Crop Protection for Mustard Traits. Cibus has agreed to collaborate with Crystal Crop Protection to develop gene-edited traits for mustard crops in India. This partnership aims to improve Brassica Juncea varieties, marking a strategic step in the company's agricultural technology efforts. The stock is currently trading near its 52-week low, with recent technical signals indicating high volatility.